Skip to search formSkip to main contentSkip to account menu

Theraloc

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

nimotuzumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, as monotherapy in patients with locally advanced or metastatic…
12504 Background: Nimotuzumab (OSAG101, Theraloc) is a humanized monoclonal antibody (mAb) that binds to the EGFR. In preclinical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)